The seroepidemiology of herpes simplex virus type 1 and 2 in Europe

Sexually Transmitted Infections

Volumn 80, Issue 3, 2004, Pages 185-191

  Pebody, R G ^a   Andrews, N ^a   Brown, D ^b   Gopal, R ^b   De Melker, H ^c   Francois G ^d   Gatcheva, N ^e   Hellenbrand, W ^f   Jokinen, S ^g   Klavs, I ^h   Kojouharova, M ^e   Kortbeek, T ^c   Kriz, B ⁱ   Prosenc, K ^h   Roubalova, K ⁱ   Teocharov, P ^e   Thierfelder, W ^f   Valle, M ^g   Van Damme, P ^d   Vranckx, R ^j  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^f ROBERT KOCH INSTITUTE   (Germany)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

ⁱ NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^j SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; BELGIUM; BULGARIA; CHILD; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; FINLAND; GERMANY; HEALTH SURVEY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SEROEPIDEMIOLOGY; SEROPREVALENCE; SLOVENIA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; SEX DISTRIBUTION;

EID: 2942575803     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2003.005850     Document Type: Review

References (47)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S, et al. Seroepidemiological and sociological patterns of herpes simplex infection in the world. Scand J Infect Dis 1990;Suppl 69:19-36.
2. Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770-5.
3. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:432-42.
4. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
5. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
6. Lafferty WE, Downey L, Celum C, et al. Herpes simplex type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181:1454-7.
7. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2: Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8.
8. Ades A, Peckham C, Dale G, et al. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Commun Health 1989;43:53-60.
9. Ross J, Smith I, Elton R. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-91. Genitourin Med 1993;69:381-3.
10. Cowan F, Johnson A, Ashley R. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996;174:470-5.
11. Lowhagen GB, Tunback P, Andersson K, et al. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex (HSV) typing and specific serology. Sex Transm Infect 2000;76:179-82.
12. Gaytant M, Steegers EA, van Cromvoirt P, et al. Incidence of herpes neonatorum in Netherlands. Ned Tijdschr Geneeskd 2000;144:1832-6.
13. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 1997;337:1105-11.
14. Armstrong G, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001;153:912-20.
15. Vyse AJ, Gay NJ, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:183-7.
16. Christenson B, Böttiger M, Svensson A, et al. A 15 year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls. J Infect 1992;25:147-54.
17. Forsgren M, Skong E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-16.
18. Persson K, Mansson A, Jonsson E, et al. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995;27:195-9.
19. Wutzler P, Doerr H, Färber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations - relevance for the incidence of genital herpes. J Med Virol 2000;61:201-7.
20. Enders G, Risse B, Zauke M, et al. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific immunoassay. Eur J Clin Microbiol Infect Dis 1998;17:870-2.
21. Bernstein D, Stanberry L. Herpes simplex virus vaccines. Vaccine 1999;17:1681-9.
22. Mathei C, Van Damme P, Bruynseels P, et al. Diphtheria immunity in Flanders. Eur Clin Microbiol Infect Dis 1997;16:631-6.
23. Klavs I, Kristančič L, Piskur-Košmač D. Unlinked anonymous HIV prevalence monitoring of pregnant women and STD patients in Slovenia in 1993. Zdrav Vestn 1994;63:659-63.
24. De Melker HE, Conyn-van Spaendonck MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiol Infect 1998;121:637-43.
25. Thefeld W, Stolzenberg H, Bellach B-M. Bundes-Gesundheitssurvey: response, Zusammensetzung der Teilnehmer und Non-Responder-Analyse. Gesundheitswesen 1999;61(Suppl 2):S57-61.
26. Gatcheva N, Vladimirova N, Nenkov P, et al. Diphtheria serosurveillance in Bulgaria: evidence of an effective TD-revaccination of young adults. 8th International Congress on Infectious Diseases, Boston, 15-18 May, 1998:275-6 (abstract).
27. Kriz P, Kriz B, Svandova E, et al. Antimeningococcal herd immunity in the Czech Republic - influence of an emerging clone, Neisseria meningitides ET-15/37. Epidemiol Infect 1999;123:193-200.
28. Gopal R, Gibbs T, Slomka MJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for serological studies in Africa. J Virol Methods 2000;87:71-80.
29. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2- specific antibodies. J Clin Lab Anal 2000;14:13-16.
30. European HSV Study Group. Standardisation of HSV assays. Unpublished document.
31. Kelly H, Riddell MA, Gidding HF, et al. A random cluster survey and convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002;20:3130-6.
32. Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
33. Van de Laar MJ, Termorshuizen F, Slomka MJ, et al. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors. Int J Epidemiol 1998;27:127-34.
34. Johnson R, Nahmias A, Magder L, et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321:7-12.
35. Schmid DS, Brown DR, Nisenbaum R, et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999;37:376-9.
36. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000;79:693-6.
37. Scoular A, Norrie J, Gillespie G, et al. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002;324:1366-7.
38. Gibson J, Hornung C, Alexander G, et al. A cross-sectional study of herpes simplex virus type 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 1990;162:306-12.
39. Peutherer JF, Smith IW, Robertson DHH. Genital infection with herpes simplex virus type 1. J Infect 1982;2:33-5.
40. Lavarty HA, Connolly JH, Russell JD. Incidence of genital herpes in Northern Ireland in 1973-83 and herpes simplex types 1 and 2 isolated in 1982-84. Genitourin Med 1986;62:24-7.
41. Barton IG, Kinghorn GR, Najern S, et al. Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis 1982;58:44-7.
42. Koelle DM, Benedetti J, Langenberg A, et al. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992;116:433-7.
43. Lafferty W, Coombs R, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection: influence of site of infection and viral type. N Engl J Med 1987;316:1444-9.
44. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20.
45. Brown Z, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
46. Forsgren M, Malm G. Herpes simplex virus and pregnancy. Scand J Infect Dis Suppl 1996;100:14-19.
47. Nahmias AJ, Josey WE, Naib ZM, et al. Antibodies to herpesvirus hominis types 1 and 2 in humans. Patients with genital herpetic infection. Am J Epidemiol 1970;91:539-46.